NewsBot
12-18-2007, 11:30 AM
<img alt="" height="1" width="1">
Alexza Completes Target Enrollment in AZ-104 Phase 2a Clinical ... (http://news.google.com/news/url?sa=T&ct=us/2-0&fd=R&url=http://money.cnn.com/news/newsfeeds/articles/prnewswire/AQTU06818122007-1.htm&cid=1125114131&ei=ovVnR9zPO4_QywSXw4A8)
CNNMoney.com - 1 hour ago
AZ-104 is a lower dose version of AZ-004, which is being developed to treat acute agitation in patients with schizophrenia or bipolar disorder. ...
More... (http://news.google.com/news/url?sa=T&ct=us/2-0&fd=R&url=http://money.cnn.com/news/newsfeeds/articles/prnewswire/AQTU06818122007-1.htm&cid=1125114131&ei=ovVnR9zPO4_QywSXw4A8)
Alexza Completes Target Enrollment in AZ-104 Phase 2a Clinical ... (http://news.google.com/news/url?sa=T&ct=us/2-0&fd=R&url=http://money.cnn.com/news/newsfeeds/articles/prnewswire/AQTU06818122007-1.htm&cid=1125114131&ei=ovVnR9zPO4_QywSXw4A8)
CNNMoney.com - 1 hour ago
AZ-104 is a lower dose version of AZ-004, which is being developed to treat acute agitation in patients with schizophrenia or bipolar disorder. ...
More... (http://news.google.com/news/url?sa=T&ct=us/2-0&fd=R&url=http://money.cnn.com/news/newsfeeds/articles/prnewswire/AQTU06818122007-1.htm&cid=1125114131&ei=ovVnR9zPO4_QywSXw4A8)